For 2020, 29 EU/EEA Member States reported 14 428 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases (14 137) corresponds to a crude rate of 4.2 cases per 100 000 population.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 February 2022, and includes updates on COVID-19, Influenza, polio, cholera, Lassa fever, and mass gathering monitoring for the Winter Olympic Games in Beijing.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 February 2022, and includes updates on COVID-19, Influenza, Lassa fever, mass gathering monitoring for the Winter Olympic Games in Beijing, Chikungunya, and dengue.
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 29 518, corresponds to a crude rate of 7.4 cases per 100 000 population.
In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.